LEXARIA BIOSCIENCE CORP. (LEXX) Return on equity 2016–2025
LEXARIA BIOSCIENCE CORP. (LEXX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-398.1%FY2025 · since FY2016: -480.1% → -398.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -398.1% | -326.0 pp |
| FY2024 | -72.1% | +146.8 pp |
| FY2023 | -218.9% | -127.5 pp |
| FY2022 | -91.5% | -60.6 pp |
| FY2021 | -30.8% | +133.7 pp |
| FY2020 | -164.6% | -329.2 pp |
| FY2019 | 164.6% | -111.7 pp |
| FY2018 | 276.4% | +346.1 pp |
| FY2017 | -69.7% | +410.4 pp |
| FY2016 | -480.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More LEXX financial trends
LEXX RevenueLEXX Net incomeLEXX Net marginLEXX Gross profitLEXX Gross marginLEXX Operating incomeLEXX Operating marginLEXX Operating cash flowLEXX Free cash flowLEXX Capital expendituresLEXX Stock buybacksLEXX Dividends paidLEXX Total assetsLEXX Total liabilitiesLEXX Shareholders’ equityLEXX overview →